The first stage of clinical trials of the coronavirus vaccine will be conducted on 60 volunteers, said the General Director of the scientific center “Vector” Rinat Maksyutov.
According to him, the center received many calls from those who want to become volunteers, both from residents of the Novosibirsk region, where the center is located and from other regions.
“At the first stage, clinical trials will be conducted on 60 volunteers. They (list of volunteers) have already been formed, and some want to among the developers of these vaccines themselves because they are confident in their effectiveness and safety,” Maksyutov said.
As a volunteer including was the chief developer of vaccines Ilnaz Gimatdinov, said General Director of “Vector.”
Doctors from different countries, including the United States, Great Britain, France, and China, are developing a vaccine against coronavirus. However, the methods for creating it differ. According to Maksyutov, there are differences between the Russian and Chinese COVID-19 vaccines. In China, a live virus is used for its production, which is developed and then inactivated. In Russia, which also had a living specimen, they chose a different path.
According to Imatdinov, scientists have taken as a basis the sequence encoding the surface spike of a viral particle, from the set of which the so-called corona is formed. “We tore it off and put the gene encoding this protein in the genome of producing cells. So, we are now able to accumulate the protein in unlimited quantities in a safe environment”, — concluded Gimatdinov.
On April 4, Maksyutov reported that prototypes of coronavirus vaccines have already passed laboratory tests on mice and ferrets, and “Vector” is ready to start the first phase of clinical trials in May.
Previously Advisor to the Director of Central Research Institute of Epidemiology of Rospotrebnadzor, academician Victor Maleev in an interview said that in the case of the most favorable development of the situation with coronavirus, the epidemic in Russia could end in June.
He noted that the timing of the end of the epidemic largely depends on how strictly Russians will observe the regime of self-isolation and other measures to prevent coronavirus.
“But we can only talk about the final victory when we develop a vaccine against coronavirus and vaccinate everyone,” Maleev said. According to him, a vaccine for the disease should be expected by the end of the year. “It will be good if it happens sooner,” he added.